Comparison of oral and patch forms of hormonal contraception on plasma lipoproteins, glycemia, clotting factors, indices of inflammation and vascular reactivity
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Feb 2011
At a glance
- Drugs Estradiol/norgestimate; Ethinylestradiol/norelgestromin
- Indications Pregnancy
- Focus Pharmacodynamics
- 11 Feb 2011 Last checked against ClinicalTrials.gov record.
- 11 Feb 2011 Planned End Date changed from 1 Jan 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 20 Aug 2008 Planned end date changed from 1 Dec 2008 to 1 Jan 2009 as reported by ClinicalTrials.gov.